CERo Therapeutics Holdings, Inc. (CERO) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for CERo Therapeutics Holdings, Inc. (CERO).

Download S&P Stocks on Google Play Download S&P Stocks on the App Store

Equity Overview

Price & Market Data

Price: $1.08

Daily Change: +$0.281 / 25.98%

Range: $0.82 - $1.42

Market Cap: $5,972,599

Volume: 71,799,251

Performance Metrics

1 Week: 85.93%

1 Month: 25.28%

3 Months: -52.77%

6 Months: -87.23%

1 Year: -99.22%

YTD: -81.50%

Company Details

Employees: 8

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.

Selected stocks

Repligen Corporation (RGEN)

Quidel Corporation (QDEL)

Zimmer Biomet Holdings, Inc. (ZBH)